#Moderna #skincancervaccine #MSD #mRNAbasedvaccine #melanoma #intismeranautogene #mRNA4157 #KEYNOTE942study #cancervaccine #highriskmelanoma #personalisedvaccine #cancerneoantigens #lungcancer #kidneycancer #bladdercancer #INTerpath001trial #solidtumours #oncology #clinicaldevelopment
zurl.co/fwe5k
zurl.co/fwe5k
Data builds behind Moderna's skin cancer vaccine
Five-year results with Moderna/MSD's melanoma jab show a 49% reduction in disease progression or death, boding well for phase 3 data later this year.
pharmaphorum.com
January 26, 2026 at 10:22 AM